We are live on ! Find out more
BIOR

Biora Therapeutics, Inc. Common Stock
BIOR

Delisted

BIOR was delisted on the 10th of December, 2024.

Back to rankings

27 hedge funds and large institutions have $84.5M invested in Biora Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
+$71.2M
2
Wells Fargo
Wells Fargo
California
+$4.71M
3
FAM
Fred Alger Management
New York
+$4.54M
4
RI
RTW Investments
New York
+$3M
5
APM
Avidity Partners Management
Texas
+$2.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Neuberger Berman Group
1
Neuberger Berman Group
New York
$58.9M +$71.2M +26,164 New
Wells Fargo
2
Wells Fargo
California
$3.9M +$4.71M +1,731 New
FAM
3
Fred Alger Management
New York
$3.75M +$4.54M +1,668 New
RI
4
RTW Investments
New York
$2.48M +$3M +1,100 New
APM
5
Avidity Partners Management
Texas
$2.15M +$2.6M +955 New
HP
6
Hound Partners
New York
$1.99M +$2.41M +884 New
SSA
7
Schonfeld Strategic Advisors
New York
$1.69M +$2.04M +750 New
Millennium Management
8
Millennium Management
New York
$1.06M +$1.29M +473 New
Citadel Advisors
9
Citadel Advisors
Florida
$900K +$1.09M +400 New
Federated Hermes
10
Federated Hermes
Pennsylvania
$900K +$1.09M +400 New
ZP
11
Zimmer Partners
New York
$900K +$1.09M +400 New
SCM
12
Stonepine Capital Management
Oregon
$865K +$1.05M +385 New
Alyeska Investment Group
13
Alyeska Investment Group
Illinois
$680K +$822K +302 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$630K +$762K +280 New
Ameriprise
15
Ameriprise
Minnesota
$601K +$727K +267 New
Goldman Sachs
16
Goldman Sachs
New York
$576K +$697K +256 New
BlackRock
17
BlackRock
New York
$540K +$654K +240 New
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$450K +$545K +200 New
CCM
19
CAAS Capital Management
New York
$360K +$436K +160 New
PCM
20
Pentwater Capital Management
Florida
$360K +$436K +160 New
MS
21
Maven Securities
Jersey
$359K +$436K +160 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$268K +$324K +119 New
ECM
23
ExodusPoint Capital Management
New York
$143K +$174K +64 New
PHK
24
Point72 Hong Kong
Hong Kong
$80K +$98K +36 New
Russell Investments Group
25
Russell Investments Group
United Kingdom
$9K +$10.9K +4 New
1
2

BIOR Hedge Fund Activity: Q2 2020 in Review

27 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Biora Therapeutics, Inc. Common Stock (BIOR) for Q2 2020, worth a combined $84.5M.

Buyers outnumbered sellers: 27 funds opened new BIOR positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Neuberger Berman Group, opening a new position worth an estimated $71.2M.

  • 27 institutional investors held Biora Therapeutics, Inc. Common Stock (BIOR) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $84.5M of Biora Therapeutics, Inc. Common Stock stock for Q2 2020.
  • 27 funds opened new Biora Therapeutics, Inc. Common Stock positions in Q2 2020 and 0 closed out, a net change of +27 holders.
  • The largest Biora Therapeutics, Inc. Common Stock buyer in Q2 2020 was Neuberger Berman Group, an estimated $71.2M added.

Based on aggregated 13F filings for Q2 2020.